Oshiumi H[au] - Search Results

Year	Number of Results
1981	1
1983	1
1998	1
2002	1
2003	4
2004	6
2005	4
2006	1
2007	3
2008	5
2009	6
2010	12
2011	8
2012	7
2013	9
2014	6
2015	13
2016	8
2017	11
2018	11
2019	4
2020	2
2021	8
2022	1

1

Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.

Tsukamoto H, Fujieda K, Miyashita A, Fukushima S, Ikeda T, Kubo Y, Senju S, Ihn H, Nishimura Y, Oshiumi H. Tsukamoto H, et al. Among authors: oshiumi h. Cancer Res. 2018 Sep 1;78(17):5011-5022. doi: 10.1158/0008-5472.CAN-18-0118. Epub 2018 Jul 2. Cancer Res. 2018. PMID: 29967259 Free article.

2

Regulation of RIG-I Activation by K63-Linked Polyubiquitination.

Okamoto M, Kouwaki T, Fukushima Y, Oshiumi H. Okamoto M, et al. Among authors: oshiumi h. Front Immunol. 2018 Jan 5;8:1942. doi: 10.3389/fimmu.2017.01942. eCollection 2017. Front Immunol. 2018. PMID: 29354136 Free PMC article. Review.

3

RIOK3 keeps MDA5 inactive.

Takashima K, Oshiumi H, Seya T. Takashima K, et al. Among authors: oshiumi h. Oncotarget. 2015 Oct 13;6(31):30423-4. doi: 10.18632/oncotarget.5265. Oncotarget. 2015. PMID: 26415216 Free PMC article. No abstract available.

4

Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity.

Tsukamoto H, Fujieda K, Senju S, Ikeda T, Oshiumi H, Nishimura Y. Tsukamoto H, et al. Among authors: oshiumi h. Cancer Sci. 2018 Mar;109(3):523-530. doi: 10.1111/cas.13433. Epub 2017 Nov 16. Cancer Sci. 2018. PMID: 29090850 Free PMC article. Review.

5

Editorial: Emerging Viruses: Host Immunity and Novel Therapeutic Interventions.

Smed-Sörensen A, Oh DY, Oshiumi H, Hsu AC. Smed-Sörensen A, et al. Among authors: oshiumi h. Front Immunol. 2018 Nov 30;9:2828. doi: 10.3389/fimmu.2018.02828. eCollection 2018. Front Immunol. 2018. PMID: 30555490 Free PMC article. No abstract available.

6

The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.

Tsukamoto H, Komohara Y, Oshiumi H. Tsukamoto H, et al. Among authors: oshiumi h. Hum Cell. 2021 Jul;34(4):1031-1039. doi: 10.1007/s13577-021-00514-2. Epub 2021 Apr 27. Hum Cell. 2021. PMID: 33905102 Review.

7

Circulating Extracellular Vesicles Carry Immune Regulatory miRNAs and Regulate Vaccine Efficacy and Local Inflammatory Response After Vaccination.

Oshiumi H. Oshiumi H. Front Immunol. 2021 Jun 15;12:685344. doi: 10.3389/fimmu.2021.685344. eCollection 2021. Front Immunol. 2021. PMID: 34211472 Free PMC article. Review.

8

[Immunobiological response against RNA virus infection].

Seya T, Oshiumi H, Matsumoto M. Seya T, et al. Among authors: oshiumi h. Uirusu. 2013;63(2):135-42. doi: 10.2222/jsv.63.135. Uirusu. 2013. PMID: 25366048 Free article. Review. Japanese.

9

Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling.

Funami K, Matsumoto M, Oshiumi H, Inagaki F, Seya T. Funami K, et al. Among authors: oshiumi h. Biochem Soc Trans. 2017 Aug 15;45(4):929-935. doi: 10.1042/BST20160259. Epub 2017 Jun 19. Biochem Soc Trans. 2017. PMID: 28630139 Review.

10

TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor-mediated inflammatory responses.

Miyashita Y, Kouwaki T, Tsukamoto H, Okamoto M, Nakamura K, Oshiumi H. Miyashita Y, et al. Among authors: oshiumi h. Life Sci Alliance. 2021 Nov 24;5(2):e202101181. doi: 10.26508/lsa.202101181. Print 2022 Feb. Life Sci Alliance. 2021. PMID: 34819358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results